Printer Friendly

Browse Liver cirrhosis topic

Development and progression subtopic



1-52 out of 52 article(s)
Title Author Type Date Words
Alcoholic liver disease: Pathogenesis and current management. Osna, Natalia A.; Donohue, Terrence M.; Kharbanda, Kusum K. Mar 22, 2017 9867
Autoimmune hepatitis in Pakistan. Dec 31, 2016 1684
Cross-sectional analysis of progressive familial intrahepatic cholestasis in Puerto Rican children. Soler, Dellys M.; Del Valle, Antonio I.; Fernandez-Lube, David; Shneider, Benjamin L. Survey Dec 1, 2016 2582
Diabetes on the increase in children; PANORAMA LIFTS THE LID ON BRUM'S EMERGING EPIDEMIC. Oct 6, 2016 416
Foie Gras: Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease. Disease/Disorder overview Sep 27, 2016 490
CARBALIVE: Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. Aug 11, 2016 505
Endothelium derived microparticles: a reliable biomarker for detection of portal hypertension in chronic hepatitis C patients. Essawy, Faiza; Mahmoud, Ola; Zahran, Manal; William, Iman; Mdkour, Mona; Sabry, Omar; Atta, Raafat; Report Jul 1, 2016 5532
Testing vitamin D levels in patients with cirrhosis. Gaby, Alan R. Brief article May 1, 2016 180
Selenium deficiency in patients with cirrhosis. Gaby, Alan R. Brief article May 1, 2016 290
Serum pro-brain natriuretic peptide (pro-BNP) in patients with cirrhosis: relation to cardiac dysfunction and severity of disease. Bogadi, Varun; Azmi, Mohammed Saad Uddin; Rao, K. Panduranga; Prabhakar, B.; Kumar, B. Ramesh; Vivek Nov 30, 2015 3981
AbbVie Announces New Data on VIEKIRA PAK (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis. Nov 14, 2015 2471
AbbVie Announces New Data on VIEKIRA PAK (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis. Nov 14, 2015 2437
Factor analysis of the biochemical markers related to liver cirrhosis. Report Oct 31, 2015 2854
HEPCIR: Cell circuits as targets and biomarkers for liver disease and cancer prevention. Aug 31, 2015 403
A study of the clinical profile of cirrhosis of liver and analysis of precipitating factors in hepatic encephalopathy. Bharathi, Sai Lakshmikanth; Vengadakrishnan, K.; Rajkumar, M. Report Aug 17, 2015 2817
Evaluation of critical flicker frequency in detecting and monitoring minimal hepatic encephalopathy. Rai, Vijan; Sharma, Vijay; Chittawar, Sachin; Choudhuri, Gourdas Clinical report Jul 30, 2015 3339
Cervical cancer along with unknown cirrhosis: a misdiagnosed case. Aminimoghaddam, Soheila; Mahmoudzadeh, Fatemeh; Maghsoudnia, Andisheh Clinical report Jul 1, 2015 1930
Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes mellitus. Murthy, Sheela Krishna; Nagesh, G.N. Jun 11, 2015 3028
Liver cirrhosis and the anticoagulant treatment--from guided indications to daily practice-case report. Dima, Nicoleta; Vata, Luminita Gina; Rezus, Elena; Rezus, Ciprian; Trifan, Anca Report Mar 1, 2015 2153
Prevalence of diabetes mellitus Type 2 in patients with chronic hepatitis c virus infection. Kaur, Ranjeet; Mohan, Gurinder; Bhalla, Narotam; Kaur, Baldeep Clinical report Jan 22, 2015 5041
Endoscopic sclerotherapy in esophageal varices: an effective treatment modality. Karbhari, S.S.; Hosamani, Veeresh; Dhaded, R.B. Clinical report Dec 8, 2014 1711
LIPIDOLIV: Role of the transcription factor ChREBP and its associated proteins in the development and progression of NAFLD (Print to RTF). Nov 20, 2014 323
Coffee consumption reduces mortality risk from Liver Cirrhosis. Sep 30, 2014 484
Does HCV make HIV infection worse? Mascolini, Mark Report Jun 22, 2014 10761
Study of resistive index in various stages of liver cirrhosis and its significance in calculating the risk for hepatorenal syndrome. Sikarwar, J.S.; Muchhoria, Shilpi; Singh, Rashmi; Bhujade, Harish; Ahirwar, Vrashbhan Report Feb 3, 2014 4013
The clinical importance of hepatitis C genotyping in the United States. O'Brien, Scott Nov 1, 2013 1931
Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India. Jain, Deepali; Nayak, Nabeen C.; Kumaran, Vinay; Saigal, Sanjiv Report Jul 1, 2013 4000
Epigenetic targets for reversing immune defects caused by alcohol exposure. Curtis, Brenda J.; Zahs, Anita; Kovacs, Elizabeth J. Report Mar 22, 2013 12343
Scientists ID factors that may predict HCV progression to severe conditions. Sep 1, 2012 653
Statins appear safe, even beneficial, in cirrhosis patients. Mahoney, Diana Aug 1, 2012 663
Statins appear safe, even beneficial, in cirrhosis patients: from the annual digestive disease week. Mahoney, Diana Clinical report Jun 15, 2012 585
Value of endothelial dysfunction in the pathogenesis of portal hypertension. Gbaruko, U.K.; Slyvka, N.O.; Bojchuk, T.M.; Ivashchuk, O.I.; Plesh, I.A.; Cherevatenko, V.O. Report Jun 1, 2012 3613
Sistema activador del plasminogeno en la enfermedad periodontal. Mendez Visag, Christian Jan 1, 2012 4125
Actinidic archaea and viroids related hepato-gastrointestinal syndrome. Kurup A., Ravikumar; Kurup, Parameswara Achutha Report Dec 31, 2011 4256
Obesity accelerates cirrhosis progression suggests study. Jul 23, 2011 270
Distribution pattern of HCV genotypes & its association with viral load. Chakravarti, Anita; Dogra, Gaurav; Verma, Vikas; Srivastava, Amit Parkash Clinical report Mar 1, 2011 3410
Hepatitis B and C anti-fibrotic strategies - the latest science. Watt, Helen Jan 1, 2011 805
The liver disease epidemic you need to know about. Stokel, Kirk Report Dec 1, 2010 1768
Alcoholic liver disease. Golden, William E.; Hopkins, Robert H. Clinical report Mar 1, 2010 760
Variceal bleeding and its dependence on portal vein size in liver cirrhotic patients. Devrajani, B. R.; Soomro, A. A.; Attra, K. M.; Qureshi, G. Ali Report Sep 1, 2009 1966
Pharmacokinetic study of frusemide in healthy and cirrhotic Indian subjects. Dhunnoo, Yuvrajsing Clinical report Jan 1, 2008 4026
Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Chang, Yoosoo; Ryu, Seungho; Sung, Eunju; Jang, Yumi Clinical report Apr 1, 2007 7375
Colchicine delays HCC in hepatitis-related cirrhosis. Moon, Mary Ann Nov 1, 2006 396
NASH and cirrhosis. (Clinical Capsules). Evans, Jeff Brief Article Aug 15, 2002 123
HCV Risks by Design. (Clinical Capsules). Kubetin, Sally Koch Dec 1, 2001 103
Is Cirrhosis of the Liver a Reversible Disease? Chejfec, Gregorio Nov 1, 2000 850
Coming or Going? What Is Cirrhosis? Geller, Stephen A. Nov 1, 2000 1234
Regression of Cirrhosis: A Timely Topic. Ray, Mukunda B. Nov 1, 2000 1027
Regression of Human Cirrhosis. Chedid, Antonio Nov 1, 2000 731
Regression of Human Cirrhosis: Morphologic Features and the Genesis of Incomplete Septal Cirrhosis. Wanless, Ian R.; Nakashima, Eisuke; Sherman, Morris Nov 1, 2000 4191
C282Y Mutation and Hepatic Iron Status in Hepatitis C and Cryptogenic Cirrhosis. Lal, Priti; Fernandes, Helen; Koneru, Baburao; Albanese, Ernest; Hameed, Meera Nov 1, 2000 3133
Quantitative study of the variability of hepatic iron concentrations. Emond, Mary J.; Bronner, Mary P.; Carlson, Timothy H.; Lin, Masami; Labbe, Robert F.; Kowdley, Kris Clinical report Mar 1, 1999 5487

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters